The trademark ELEVATE was filed by Alnylam Pharmaceuticals, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on June 15, 2021, and received one opposition filed on September 15, 2021 by Apeiron Investment Group Ltd on (a) Identity of marks and Goods and Services, (b) Likelihood of confusion. the opponent was represented by Zirngibl Rechtsanwälte Partnerschaft mbB and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued September 15, 2021
The application was filed in English, and English was also language of all opposition proceedings (Italian was selected as the second language).